ABT vs TREE · P/E 25, rev $44.33B vs P/E 2.8, rev $900.2M
Abbott Laboratories (ABT) versus Lendingtree Inc (TREE) — a side-by-side from cached financials, not a winner call.
Abbott Laboratories (ABT) is a medical devices company listed on NYSE.
Lendingtree Inc (TREE) is a financial conglomerates company listed on NASDAQ.
Latest reported ABT revenue for 2025-12-31 was $44.33B. Net income was $6.52B. Revenue was up 5.7% from 2024-12-31 to 2025-12-31. ABT currently screens at market cap $154.15B and trailing P/E 24.8.
Latest reported TREE revenue for 2024-12-31 was $900.2M. Net income was -$41.7M. Revenue was up 33.9% from 2023-12-31 to 2024-12-31. TREE currently screens at market cap $499.8M and trailing P/E 2.8.
ABT currently screens at market cap $154.15B and trailing P/E 24.8. TREE currently screens at market cap $499.8M and trailing P/E 2.8.
Not investment advice. Open the ABT and TREE stock pages for the full models.
Not investment advice.